Podchaser Logo
Home
Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Released Tuesday, 5th December 2023
Good episode? Give it some love!
Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Tuesday, 5th December 2023
Good episode? Give it some love!
Rate Episode

Editor’s Summary by Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for the December 5, 2023, issue.

Related Content:

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features